Top

Journal of Medical Case Reports

Published in:

Open Access 01-12-2014 | Case report

Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report

Authors: Chun Shan, Guo Qing Yin, Pei Wu

Published in: Journal of Medical Case Reports | Issue 1/2014

Abstract

Introduction

Five nucleos(t)ide analogs are used to treat chronic hepatitis B. Ideal nucleos(t)ide analog therapy in chronic hepatitis B patients with kidney transplantation must ensure virological suppression and minimize renal injury. However, resistance to nucleos(t)ide analogs frequently results in virological breakthrough, hepatitis flare, and complicated deterioration of the transplanted kidney. Inappropriate rescue therapy for drug resistance may subsequently cause hepatitis B virus multidrug resistance. Currently, tenofovir is used to treat chronic hepatitis B patients with kidney transplantation. In the field, we first reported combination therapy with tenofovir plus entecavir in a kidney transplant chronic hepatitis B patient with nucleos(t)ide analog multidrug resistance.

Case presentation

A 50-year-old Chinese man with chronic hepatitis B and kidney transplantation received nucleos(t)ide analog therapy with sequential monotherapy and combination therapy. Virological parameters, hepatic enzymology and renal function were monitored. Drug-resistance mutations were detected by sequence analysis. Our patient received sequential nucleos(t)ide analog monotherapy and inappropriate combination therapy during 132 months, which caused multidrug resistance and renal functional injury. Entecavir plus adefovir was administered in month 106, resulting in decreased hepatitis B virus load, normal hepatic function, and stabilized creatinine clearance. As a result of rebounded viral load and significantly declining creatinine clearance, tenofovir plus entecavir was administered in month 133. After eight weeks, undetectable hepatitis B virus DNA, normal hepatic function and improved creatinine clearance were present. Compared with combination therapy with adefovir plus entecavir, tenofovir plus entecavir showed a potent antiviral effect for multidrug resistance and minimized renal injury.

Conclusions

In chronic hepatitis B patients with kidney transplantation, sequential monotherapy with antiviral agents with low barriers to resistance should be avoided, and initial therapy with entecavir is a better option. Combination therapy with tenofovir plus entecavir in this setting with multidrug resistance is safe and effective.

Available only for authorised users

Papatheodoridis G, Buti M, Cornberg M, Janssen HL, Mutimer D, Pol S, Raimondo G, Dusheiko G, Lok A, Marcellin P: EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012, 57: 167-185.CrossRef

Gish R, Jia JD, Locarnini S, Zoulim F: Selection of chronic hepatitis B therapy with high barrier to resistance. Lancet Infect Dis. 2012, 12: 341-353. 10.1016/S1473-3099(11)70314-0.CrossRefPubMed

Vallet-Pichard A, Fontaine H, Mallet V, Pol S: Viral hepatitis in solid organ transplantation other than liver. J Hepatol. 2011, 55: 474-482. 10.1016/j.jhep.2011.01.003.CrossRefPubMed

Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S, Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008, 2: 263-283. 10.1007/s12072-008-9080-3.CrossRefPubMedPubMedCentral

Pipili CL, Papatheodoridis GV, Cholongitas EC: Treatment of hepatitis B in patients with chronic kidney disease. Kidney Int. 2013, 84: 880-885. 10.1038/ki.2013.249.CrossRefPubMed

Daudé M, Rostaing L, Sauné K, Lavayssière L, Basse G, Esposito L, Guitard J, Izopet J, Alric L, Kamar N: Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients. Transplantation. 2011, 91: 916-920. 10.1097/TP.0b013e3182100f59.CrossRefPubMed

Das P, Vivek V, Ford M, Kingdon E, Holt S: Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir. BMJ Case Rep. 2011

Haque SK, Ariceta G, Batlle D: Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant. 2012, 27: 4273-4287. 10.1093/ndt/gfs493.CrossRefPubMedPubMedCentral

Gara N, Zhao X, Collins MT, Chong WH, Kleiner DE, Jake Liang T, Ghany MG, Hoofnagle JH: Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther. 2012, 35: 1317-1325. 10.1111/j.1365-2036.2012.05093.x.CrossRefPubMedPubMedCentral

10.

Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Niño MD, Izquierdo MC, Poveda J, Sainz-Prestel V, Ortiz-Martin N, Parra-Rodriguez A, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A: Tenofovir nephrotoxicity 2011 update. AIDS Res Treat. 2011, 2011: 354908-PubMedPubMedCentral

11.

Mauss S, Berger F, Filmann N, Hueppe D, Henke J, Hegener P, Athmann C, Schmutz G, Herrmann E: Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B. J Hepatol. 2011, 55: 1235-1240. 10.1016/j.jhep.2011.03.030.CrossRefPubMed

12.

de Vries-Sluijs TE, Reijnders JG, Hansen BE, Zaaijer HL, Prins JM, Pas SD, Schutten M, Hoepelman AI, Richter C, Mulder JW, de Man RA, Janssen HL, van der Ende ME: Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology. 2010, 139: 1934-1941. 10.1053/j.gastro.2010.08.045.CrossRefPubMed

13.

Coffin CS, Mulrooney-Cousins PM, Peters MG, van Marle G, Roberts JP, Michalak TI, Terrault NA: Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat. 2011, 18: 415-423. 10.1111/j.1365-2893.2010.01321.x.CrossRefPubMedPubMedCentral

14.

Liu F, Chen L, Yu DM, Deng L, Chen R, Jiang Y, Chen L, Huang SY, Yu JL, Gong QM, Zhang XX: Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy. Gut. 2011, 60: 1269-1277. 10.1136/gut.2010.226225.CrossRefPubMed

Title: Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report
Authors: Chun Shan
Guo Qing Yin
Pei Wu
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Journal of Medical Case Reports / Issue 1/2014
Electronic ISSN: 1752-1947
DOI: https://doi.org/10.1186/1752-1947-8-281

At a glance: The STEP trials

Springer Medicine

Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report

Abstract

Introduction

Case presentation

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Fulminant systemic capillary leak syndrome due to C1 inhibitor deficiency complicating acute dermatomyositis: a case report

Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report

Streptococcus acidominimus causing invasive disease in humans: a case series

Treatment of an aggressive aneurysmal bone cyst with percutaneous injection of polidocanol: a case report

Chilaiditi syndrome presenting as chest pain in an adult patient: a case report

Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report